Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The company has filed a disclosure under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30), which is a standard regulatory filing format used to inform the stock exchanges about material events or corporate updates. The specific details of the update are not available in the provided headline, as the headline only references the regulatory provision under which the filing was made. Shareholders would need to refer to the full filing or the company's investor relations page to understand the actual content of this update.
Without the full details of the filing, the impact on shareholders or the stock cannot be determined. Investors should review the complete announcement for any material information that could affect the company's operations, financials, or governance.